Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

Description

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Conditions

Medication Administered in Error

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

A Randomized, Controlled Study of a Health Literacy-informed Technology-based Approach to Support Safe Medication Use by Parents After Discharge of Infants From the Neonatal Intensive Care Unit.

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

Condition
Medication Administered in Error
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. English or Spanish-speaking
  • 2. 18 years of age and older
  • 3. Child discharged home with a Rx for \>1 daily liquid medication (other than multivitamin)
  • 4. Primary person who will administers child's medications.
  • 5. Willingness and ability to participate
  • 1. Does not have a working phone number
  • 2. Does not have access to internet (via computer/smartphone)
  • 3. Does not have a mobile phone that receives texts.
  • 4. Not able to return to the hospital for their child's follow-up visit
  • 5. Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
  • 6. Uncorrectable hearing impairment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Hsiang Sharon Yin, PRINCIPAL_INVESTIGATOR, NYU Langone

Study Record Dates

2026-02